Primary analysis of MASTERKEY-265 phase 1b study of talimogene laherparepvec (T-VEC) and pembrolizumab (pembro) for unresectable stage IIIB-IV melanomaReinhard Dummer,Georgina V. Long,Antoni Ribas,Igor Puzanov,Olivier Michielin,Ari VanderWalde,Robert H. I. Andtbacka,Jonathan Cebon,Eugenio Fernandez,Josep Malvehy,Anthony J. Olszanski,Thomas F. Gajewski,John M. Kirkwood,Christine Gause,Lisa Chen,David R. Kaufman,Jeffrey Chou,F. Stephen HodiJOURNAL OF TRANSLATIONAL MEDICINE（2016）引用 64|浏览37暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
